1.
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
by Nagashima, M
Diabetologia, 2011-07-24, Vol.54 (10), p.2649-2659

2.
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
by Wang, Zeneng
Nature medicine, 2007-10, Vol.13 (10), p.1176-1184

3.
New Therapy via Targeting Androgen Receptor in Monocytes/Macrophages to Battle Atherosclerosis
by HUANG, Chiung-Kuei
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (6), p.1345-1353

4.
Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis
by Gleissner, Christian A
Hypertension (Dallas, Tex. 1979), 2007-08, Vol.50 (2), p.276-283

5.
Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages
by Watanabe, Takuya
Hypertension (Dallas, Tex. 1979), 2005-10, Vol.46 (4), p.738-744

6.
Dihydrotestosterone Suppresses Foam Cell Formation and Attenuates Atherosclerosis Development
by Qiu, Yang
Endocrine reviews, 2010-06, Vol.31 (3), p.401-401

7.
Production of Inflammatory Molecules in Peripheral Blood Mononuclear Cells from Severely Glucose-6-Phosphate Dehydrogenase-Deficient Subjects
by Sanna, Francesca
Journal of vascular research, 2007-06, Vol.44 (4), p.253-263

8.
Chlamydia pneumoniae and atherosclerosis: Links to the disease process
by Byrne, Gerald I
The American heart journal, 1999, Vol.138 (5), p.S488-S490

9.
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation
by Dushkin, M I
Bulletin of experimental biology and medicine, 2007-11, Vol.144 (5), p.713-716

10.
Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells
by Katabuchi, Hidetaka
Medical electron microscopy, 2003-12, Vol.36 (4), p.253-262

11.
PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation
by Yin, Ran
Acta pharmacologica Sinica, 2006-09, Vol.27 (9), p.1146-1152

12.
Effects of CpG-ODN on gene expression in formation of foam cells
by Li, Kai
Acta pharmacologica Sinica, 2005-11, Vol.26 (11), p.1359-1364

13.
Mammary ductal foam cells: Macrophage immunophenotype
by Dabbs, David J
Human pathology, 1993, Vol.24 (9), p.977-981

14.
Characterization of cells cultured from early lactation milks
by Ceriani, R. L.
In Vitro, 1979-05, Vol.15 (5), p.356-362

15.
Endogenous splenic colonies and megakaryopoiesis in methylcellulose treated irradiated mice
by Bernabei, P. A.
Experientia, 1985-01, Vol.41 (1), p.97-99

16.
The macrophage foam cell as a target for therapeutic intervention
by Glass, Christopher K
Nature medicine, 2002-11, Vol.8 (11), p.1235-1242

17.
The role of hypoxia-inducible factor 1 in atherosclerosis
by Gao, Linggen
Journal of Clinical Pathology, 2012-10, Vol.65 (10), p.872-876

18.
Toll-Like Receptor-4 and Lipoprotein Accumulation in Macrophages
by Miller, Yury I
Trends in cardiovascular medicine, 2009, Vol.19 (7), p.227-232

19.
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
by Hotamisligil, Gökhan S
Nature medicine, 2001-06, Vol.7 (6), p.699-705

20.
Atypical lymphocytes and leukocytes in the peripheral circulation of caged hens
by Cotter, Paul F
Poultry science, 2015-07-01, Vol.94 (7), p.1439-1445
